Hedge Funds Pile Into Healthcare Stocks Amid AI Drug Discovery Boom
Hedge funds boosted bullish healthcare exposure to a 5-year high, driven by AI-assisted drug discovery, robust M&A activity ($173B expected in 2026), and record specialist fund returns nearing 40%.